CCL4 and fibrosis: The efficacy of PPAR α/δ dual agonist GFT505 had been evaluated in several animal models previously, including western diet-fed human APOE2 transgenic mice, MCD diet-fed db/db mice and CCL4-induced fibrosis rats [9, 17].